HIGHLIGHTS
- who: Parisa Gazerani from the Laboratory of Molecular Pharmacology, Department of Health Science and Technology, Faculty of Medicine, Denmark, Faculty of Pharmaceutical Sciences, The of British Columbia, Vancouver, BC have published the paper: Sex-Specific Pharmacotherapy for Migraine: A Narrative Review, in the Journal: (JOURNAL) of 29/Dec/2019
- what: Assuming that the efficacy in the study of women alone is representative of the effectiveness of Excedrin, a simple calculation based on the population with the highest percentage of men in the Lipton et_al study can be used to estimate efficacy in men.
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.